Semaglutide drugs now include rare vision risk warning as studies link long-term use to optic neuropathy, macular ...

The European Medicines Agency has identified a rare eye condition risk linked to Novo Nordisk’s semaglutide drugs.

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye ...

US woman Caroline Davis shared incredible before and after images of her weight loss after using semaglutide drug Wegovy.

So, what's the tea on microdosing? It's pretty much what it sounds like — taking smaller doses than the usual prescribed ...

Ozempic, which was introduced into the UK in January 2019, having previously been approved in the US in 2017, is an ...

The rising trend of sweet-smelling gourmand fragrances coincides with anecdotal reports from GLP-1 weight-loss drug users ...

Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...

The former glamour model, 47, previously revealed the 23-year-old son was going on the weight-loss injections in a bid to ...

Weight-loss jabs could stop the contraceptive pill working and lead to unwanted pregnancies, health officials have warned.